RENE.L - ReNeuron Group plc

LSE - LSE Delayed Price. Currency in GBp
0.000 (0.000%)
At close: 4:30PM BST
Stock chart is not supported by your current browser
Previous Close1.675
Bid0.000 x 10000000
Ask0.000 x 60000000
Day's Range1.651 - 1.685
52 Week Range1.550 - 3.675
Avg. Volume2,248,104
Market Cap53.01M
PE Ratio (TTM)-3.35
EPS (TTM)-0.5
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • One Thing To Consider Before Buying ReNeuron Group plc (AIM:RENE)
    Simply Wall St.14 days ago

    One Thing To Consider Before Buying ReNeuron Group plc (AIM:RENE)

    If you are a shareholder in ReNeuron Group plc’s (AIM:RENE), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of yourRead More...

  • Accesswire3 months ago

    Edison Issues Update on ReNeuron Group (RENE)

    LONDON, UK / ACCESSWIRE / July 6, 2017 / The highlight of FY17 was positive Phase II efficacy data from ReNeuron's PISCES II clinical trial. As this and its other clinical programmes in ophthalmology and ...

  • We're sorry this is all we were able to find about this topic.